Skip to main content
HR 4278 117th Congress House Health

To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.

Introduced: June 30, 2021 Introduced by: Murphy, Gregory F. Republican · North Carolina See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 1, 2021
Referred to the Subcommittee on Health.
Jun 30, 2021
Referred to the House Committee on Energy and Commerce.
Jun 30, 2021
Introduced in House
 Plain-English summary Congressional Research Service

This bill requires the Government Accountability Office to study and report on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers.

What's happening now July 1, 2021

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Republican 1